CIK 0000944809
- Accelerated filer
OPKO HEALTH, INC.
Sign in to watch- Ticker
- OPK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 752402409
- Phone
- +1 305-575-4181
- Business address
- 4400 BISCAYNE BLVD., MIAMI, FL, 33137
- Former names
- EXEGENICS INC, eXegenics Inc, CYTOCLONAL PHARMACEUTICS INC /DE
- 4 Open-market buy CEO & Chairman bought 200,000 shares at an average $2.54 ($507,949)
- 4 Open-market buy CEO & Chairman bought 350,000 shares at an average $2.29 ($802,103)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Innovation Officer bought 240,000 shares at an average $2.49 ($597,393)
- 4/A Grant or award Chief Innovation Officer acquired 39,555,028 shares (grant or award)
- 4/A Grant or award Vice Chairman and President acquired 39,555,028 shares (grant or award)
- 4 Open-market buy CEO & Chairman bought 200,000 shares at an average $2.39 ($478,857)
- 4 Open-market buy CEO & Chairman bought 100,000 shares at an average $2.31 ($231,327)
- 4 Open-market buy CEO & Chairman bought 100,000 shares at an average $2.36 ($236,498)
- 4 Open-market buy CEO & Chairman bought 100,000 shares at an average $2.79 ($279,227)
- 4 Open-market buy CEO & Chairman bought 50,000 shares at an average $2.95 ($147,614)
- 4 Open-market buy CEO & Chairman bought 50,000 shares at an average $3.02 ($151,177)
- 4 Open-market buy CEO & Chairman bought 50,000 shares at an average $2.98 ($148,866)
- 4 Open-market buy Chief Innovation Officer bought 75,471 shares at an average $2.88 ($217,121)
Page 8 of 106 · 2,118 filings